L3VLUP
Quarter end
30 Sep 2025
the date the book describes
Filed
14 Nov 2025
up to 45 days after the quarter end
Managers listing it
1
at least, of 95 tracked, among listed positions
Comparable managers
95
filed both Q2 2025 and Q3 2025; 1 listed it in both
Shares listed
398,857
combined, among listed positions
Reported value
$1.1m
combined, at the quarter end

Among the 95 comparable managers: 1 buyer (opened or added shares) and 0 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +226,023.

Managers listing HCAT in Q3 2025

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q2 2025, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

1 of 1 holder

ActionFiling
Moore Capital Management LP398,857$1.1munder 0.1%Added+226,02314 Nov 2025 (the filing on sec.gov)

Largest increases and reductions, by shares

Q2 2025 to Q3 2025, among managers that listed it in both quarters or opened it.

Increases

Reductions

No reduction among listed positions.

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (0)

No new position among listed positions.

Exited (0)

No exit shown by a manager’s own filing.

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
2 in Q3 2023 to 1 in Q3 2025

Tracked managers listing it, at least.

051015202020212022202320242025
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
HCAT by quarter
QuarterHoldersReported valueBuyersSellers
Q3 20194$9.8mn.a.n.a.
Q4 20193$8.6mn.a.n.a.
Q1 20206$55mn.a.n.a.
Q2 20206$104mn.a.n.a.
Q3 20207$231mn.a.n.a.
Q4 202010$329mn.a.n.a.
Q1 20218$342mn.a.n.a.
Q2 202113$409mn.a.n.a.
Q3 202110$374mn.a.n.a.
Q4 20216$280mn.a.n.a.
Q1 20223$200mn.a.n.a.
Q2 20224$93mn.a.n.a.
Q3 20227$35mn.a.n.a.
Q4 20225$31mn.a.n.a.
Q1 20234$31mn.a.n.a.
Q2 20233$38mn.a.n.a.
Q3 20232$45mn.a.n.a.
Q4 20233$48m21
Q1 20242$9.5m11
Q2 20241$2.8m01
Q3 20241$992k01
Q1 20251$989k10
Q2 20251$652k01
Q3 20251$1.1m10

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

HCAT and GOOGL →HCAT and META →HCAT and SPCX →Choose a stock to compare with HCAT →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own HCAT, latest filings →Back to the 13F Explorer →